Case Study

Patient Enrollment For Global Gout Study

Source: Acurian
Patient Enrollment For Global Gout Study

This phase III global program, involving four protocols and approximately 300 sites, was critical for a sponsor striving to make its compound the leader in a potential $1B gout market by 2018.

After five months of enrollment, things were not looking good. See what this sponsor did to get back on track.